Social Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Social Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-08-18FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma's supplemental application to market a generic fluvoxamine maleate product.
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Yaopharma Co., Ltd.)
FDA approved a supplemental application for venlafaxine hydrochloride from Yaopharma Co., Ltd., enabling the generic drug to be marketed. Th…
-
FDA approval · 2023-08-18FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Alvogen, Inc.)
FDA approved a supplemental application for sertraline hydrochloride (Alvogen), resulting in labeling changes to the approved NDA.
-
FDA approval · 2023-08-18FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) from Viatris Specialty LLC. The approval updates the …
-
FDA approval · 2023-08-18FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for paroxetine submitted by Padagis US LLC. This action represents an additional regulatory appr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Venlafaxine Hydrochloride from Dr. Reddy's Laboratories Limited for a generic venlafaxine hydroc…
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Venlafaxine from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. under an ANDA.
-
FDA approval · 2023-08-09FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc., indicating an update to the produ…
-
FDA approval · 2023-06-07FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride by Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Wiring Adolescents With Social Anxiety Via Behavioral Interventions [NA]
A completed clinical trial assessing behavioral interventions for social anxiety in adolescents; results posted in 2023.
-
FDA approval · 2023-05-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved a generic version of venlafaxine hydrochloride from Granules Pharmaceuticals Inc. via an Original Application (ANDA), a generic…
-
FDA approval · 2023-04-12FDA Approved: VENLAFAXINE — Original Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s original generic application for venlafaxine. The approval covers generic venlafaxine for the treatmen…
-
FDA approval · 2023-03-31FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for Granules Pharmaceuticals' sertraline hydrochloride generic product, enabling its marketing in th…
-
FDA approval · 2023-03-30FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA granted supplemental approval for a generic venlafaxine hydrochloride product from Aurobindo Pharma Limited.
-
FDA approval · 2023-03-23FDA Approved: PAROXETINE — Supplemental Application (Modavar Pharmaceuticals LLC)
FDA approved a supplemental application for generic paroxetine filed by Modavar Pharmaceuticals LLC under ANDA212645.
-
CLINICAL_TRIALS trial_result · 2023-02-14Clinical Trial Update: Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study [Phase 3]
An 8-week pilot Phase 3 trial evaluating cannabidiol for anxiety disorders, including generalized anxiety disorder and social anxiety disord…
-
FDA approval · 2023-01-31FDA Approved: PAROXETINE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for paroxetine from ANI Pharmaceuticals, indicating an approved change to the product (e.g., lab…
-
FDA approval · 2023-01-25FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
The FDA approved a supplemental application for Zoloft (sertraline hydrochloride) filed by Roerig.
-
FDA approval · 2023-01-13FDA Approved: ALPRAZOLAM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for alprazolam from Mylan Pharmaceuticals Inc., indicating a revised or expanded approval under an N…
-
FDA approval · 2022-12-05FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA has approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride, allowing the generic to be marketed as part o…
-
FDA approval · 2022-11-29FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for escitalopram oxalate (a generic version of Lexapro), enabling market entry…
-
FDA approval · 2022-11-28FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approves the original application for venlafaxine hydrochloride tablets from Rising Pharma Holdings, Inc., making a generic version …
-
FDA approval · 2022-11-21FDA Approved: VENLAFAXINE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for venlafaxine submitted by Ascend Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Group Cognitive-behavioral Intervention for Social Anxiety in Schizophrenia [Phase 1, Phase 2]
This clinical trial update reports on a group cognitive-behavioral intervention for social anxiety in individuals with schizophrenia, coveri…
-
FDA approval · 2022-08-30FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride as a generic, confirming approval under the ANDA p…